Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy

Abstract Background Radiomic analysis of quantitative features extracted from segmented medical images can be used for predictive modeling of prognosis in brain tumor patients. Manual segmentation of the tumor components is time-consuming and poses significant reproducibility issues. We compare the...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Wan, Clifford Lindsay, Chenxi Zhang, Jisoo Kim, Xin Chen, Jing Li, Raymond Y. Huang, David A. Reardon, Geoffrey S. Young, Lei Qin
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cancer Imaging
Subjects:
Online Access:https://doi.org/10.1186/s40644-024-00818-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585420922159104
author Qi Wan
Clifford Lindsay
Chenxi Zhang
Jisoo Kim
Xin Chen
Jing Li
Raymond Y. Huang
David A. Reardon
Geoffrey S. Young
Lei Qin
author_facet Qi Wan
Clifford Lindsay
Chenxi Zhang
Jisoo Kim
Xin Chen
Jing Li
Raymond Y. Huang
David A. Reardon
Geoffrey S. Young
Lei Qin
author_sort Qi Wan
collection DOAJ
description Abstract Background Radiomic analysis of quantitative features extracted from segmented medical images can be used for predictive modeling of prognosis in brain tumor patients. Manual segmentation of the tumor components is time-consuming and poses significant reproducibility issues. We compare the prediction of overall survival (OS) in recurrent high-grade glioma(HGG) patients undergoing immunotherapy, using deep learning (DL) classification networks along with radiomic signatures derived from manual and convolutional neural networks (CNN) automated segmentation. Materials and methods We retrospectively retrieved 154 cases of recurrent HGG from multiple centers. Tumor segmentation was performed by expert radiologists and a convolutional neural network (CNN). From the segmented tumors, 2553 radiomic features were extracted for each case. A robust feature subset was selected using intraclass correlation coefficient analysis between manual and automated segmentations. The data was divided into a 9:1 ratio and validated through ten-fold cross-validation and tested on a rotating test set. Features selection was done by the Kruskal–Wallis test. The Radiomics-based OS predictions, generated using Support Vector Machine (SVM), were compared between the two segmentation approaches and against OS prediction by the CNN model adapted for classification. Model efficacy was evaluated using the area under the receiver operating characteristic curve (AUC). Results The clinical model AUC for OS prediction was 0.640 ± 0.013 (mean ± 95% confidence interval) in the training set and 0.610 ± 0.131 in the test set. The radiomics prediction of OS based on manual segmentation outperformed automatic segmentation (AUC of 0.662 ± 0.122 vs. 0.471 ± 0.086, respectively) in the test set. Robust features improved the performance of manual segmentation to AUC of 0.700 ± 0.102, of automated segmentation to 0.554 ± 0.085. The CNN prognosis model demonstrated promising results, with an average AUC of 0.755 ± 0.071 for training sets and 0.700 ± 0.101 for the test set. Conclusion Manual segmentation-derived radiomic features outperformed automated segmentation-derived features for predicting OS in recurrent high-grade glioma patients undergoing immunotherapy. The end-to-end CNN prognosis model performed similarly to radiomics modeling using manual-segmentation-derived features without the need for segmentation. The potential time-saving must be weighed against the lower interpretability of end-to-end black box modeling.
format Article
id doaj-art-4f64974697234e80b48186832708d64f
institution Kabale University
issn 1470-7330
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj-art-4f64974697234e80b48186832708d64f2025-01-26T12:50:37ZengBMCCancer Imaging1470-73302025-01-012511910.1186/s40644-024-00818-0Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapyQi Wan0Clifford Lindsay1Chenxi Zhang2Jisoo Kim3Xin Chen4Jing Li5Raymond Y. Huang6David A. Reardon7Geoffrey S. Young8Lei Qin9Department of Radiology, the Key Laboratory of Advanced Interdisciplinary Studies Center, the First Affiliated Hospital of Guangzhou Medical UniversityDepartment of Radiology, Division of Biomedical Imaging and Bioengineering, UMass Chan Medical SchoolDigital Medical Research Center, School of Basic Medical Sciences, Fudan UniversityDepartment of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolGuangzhou First People’s Hospital, School of Medicine, South China University of TechnologyDepartment of Radiology, the Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital)Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolCenter for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolDepartment of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Imaging, Dana-Farber Cancer Institute, Harvard Medical SchoolAbstract Background Radiomic analysis of quantitative features extracted from segmented medical images can be used for predictive modeling of prognosis in brain tumor patients. Manual segmentation of the tumor components is time-consuming and poses significant reproducibility issues. We compare the prediction of overall survival (OS) in recurrent high-grade glioma(HGG) patients undergoing immunotherapy, using deep learning (DL) classification networks along with radiomic signatures derived from manual and convolutional neural networks (CNN) automated segmentation. Materials and methods We retrospectively retrieved 154 cases of recurrent HGG from multiple centers. Tumor segmentation was performed by expert radiologists and a convolutional neural network (CNN). From the segmented tumors, 2553 radiomic features were extracted for each case. A robust feature subset was selected using intraclass correlation coefficient analysis between manual and automated segmentations. The data was divided into a 9:1 ratio and validated through ten-fold cross-validation and tested on a rotating test set. Features selection was done by the Kruskal–Wallis test. The Radiomics-based OS predictions, generated using Support Vector Machine (SVM), were compared between the two segmentation approaches and against OS prediction by the CNN model adapted for classification. Model efficacy was evaluated using the area under the receiver operating characteristic curve (AUC). Results The clinical model AUC for OS prediction was 0.640 ± 0.013 (mean ± 95% confidence interval) in the training set and 0.610 ± 0.131 in the test set. The radiomics prediction of OS based on manual segmentation outperformed automatic segmentation (AUC of 0.662 ± 0.122 vs. 0.471 ± 0.086, respectively) in the test set. Robust features improved the performance of manual segmentation to AUC of 0.700 ± 0.102, of automated segmentation to 0.554 ± 0.085. The CNN prognosis model demonstrated promising results, with an average AUC of 0.755 ± 0.071 for training sets and 0.700 ± 0.101 for the test set. Conclusion Manual segmentation-derived radiomic features outperformed automated segmentation-derived features for predicting OS in recurrent high-grade glioma patients undergoing immunotherapy. The end-to-end CNN prognosis model performed similarly to radiomics modeling using manual-segmentation-derived features without the need for segmentation. The potential time-saving must be weighed against the lower interpretability of end-to-end black box modeling.https://doi.org/10.1186/s40644-024-00818-0High-grade gliomaConvolutional neural networksDeep learningRadiomicsOverall survival
spellingShingle Qi Wan
Clifford Lindsay
Chenxi Zhang
Jisoo Kim
Xin Chen
Jing Li
Raymond Y. Huang
David A. Reardon
Geoffrey S. Young
Lei Qin
Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
Cancer Imaging
High-grade glioma
Convolutional neural networks
Deep learning
Radiomics
Overall survival
title Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
title_full Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
title_fullStr Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
title_full_unstemmed Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
title_short Comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high-grade glioma treated with immunotherapy
title_sort comparative analysis of deep learning and radiomic signatures for overall survival prediction in recurrent high grade glioma treated with immunotherapy
topic High-grade glioma
Convolutional neural networks
Deep learning
Radiomics
Overall survival
url https://doi.org/10.1186/s40644-024-00818-0
work_keys_str_mv AT qiwan comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT cliffordlindsay comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT chenxizhang comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT jisookim comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT xinchen comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT jingli comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT raymondyhuang comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT davidareardon comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT geoffreysyoung comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy
AT leiqin comparativeanalysisofdeeplearningandradiomicsignaturesforoverallsurvivalpredictioninrecurrenthighgradegliomatreatedwithimmunotherapy